Our Story

Antibody-based therapies have become established over the past 20 years, and has become one of the most important and successful strategies for treating patients with a number of diseases that were previously untreatable. With new formats, technologies and methods being developed every year, the antibody industry is fast moving and can be difficult to keep up with.

In the 13 years that the European Antibody Congress has run, there have been countless breakthroughs, advancements and achievements that not only were showcased for the first time at the European Antibody Congress, but were also born out of collaborations and partnerships that were catalysed by, or initiated, at the European Antibody Congress.

Our mission, for every European Antibody Congress, is to bring you the very best speakers from big pharma, biotechs, academia and technology innovators to discuss with you the most exciting breakthroughs when it comes to the discovery and development of antibodies. Whether that’s the newest format of a cancer killing ADC, the most advanced screening technology for mAbs, or the clinical development of a bispecific with promises to treat Alzheimer’s disease, we want to give you access to all of this to grow your knowledge, grow your business, and grow your connections.

As part of the Festival of Biologics, the European Antibody Congress will be co-located with World Biosimilar Congress, World Immunotherapy Congress and HPAPI World Congress. Attendees will have access to plenty of content across the 3 days and more networking opportunities than ever before with over 800+ leading industry professionals.

We look forward to welcoming you to Basel. 

 

REGISTER NOW

 

Co-located with 

Part of


European Antibody Congress 29-31 October, Basel, Switzerland

Part of the  Festival of Biologics

Sign Up for Event Updates